STOP Persistent AF
Sponsor: Medtronic Cardiac Ablation Solutions
A NA clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Medtronic Cardiac Ablation Solutions and has accumulated 20 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Mar 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 15 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Sep 2020 — Nov 2020 [monthly]
Completed NA
-
Feb 2020 — Sep 2020 [monthly]
Completed NA
-
Nov 2019 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2018 — Nov 2019 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Dec 2017 — Feb 2018 [monthly]
Recruiting NA
-
Oct 2017 — Dec 2017 [monthly]
Recruiting NA
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → NA
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .